The RNA‐binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma

CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma

(2020) Beatriz Salvador-Barbero et al.   CANCER CELL

MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma

(2020) Xing Wang et al.   Cancer Cell International

MEX3A regulates Lgr5 + stem cell maintenance in the developing intestinal epithelium

(2020) Bruno Pereira et al.   EMBO REPORTS

Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma

(2020) Swati Venkat et al.   GENOME RESEARCH

PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications

(2020) Heng Zhu et al.   Molecular Cancer

Genomic basis for RNA alterations in cancer

(2020) Claudia Calabrese et al.   NATURE

How RNA-Binding Proteins Interact with RNA: Molecules and Mechanisms

(2020) Meredith Corley et al.   MOLECULAR CELL

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Immunotherapy and targeted therapy combinations in metastatic breast cancer

(2019) Francisco J Esteva et al.   LANCET ONCOLOGY

Alternative cleavage and polyadenylation in health and disease

(2019) Andreas J. Gruber et al.   NATURE REVIEWS GENETICS

Targeting mRNA processing as an anticancer strategy

(2019) Joana Desterro et al.   NATURE REVIEWS DRUG DISCOVERY

Altered RNA Processing in Cancer Pathogenesis and Therapy

(2019) Esther A. Obeng et al.   Cancer Discovery

The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle invasive bladder cancer.

(2018) Pamela Bielli et al.   CLINICAL CANCER RESEARCH

Therapeutic developments in pancreatic cancer: current and future perspectives

(2018) John P. Neoptolemos et al.   Nature Reviews Gastroenterology & Hepatology

Mex-3B induces apoptosis by inhibiting miR-92a access to the Bim-3′UTR

(2018) Takeaki Oda et al.   ONCOGENE

Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers

(2018) Ze-Lin Wang et al.   Cell Reports

Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment

(2018) Lan Thi Hanh Phi et al.   Stem Cells International

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

(2018) André Kahles et al.   CANCER CELL

Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4

(2018) Francesca Zanconato et al.   NATURE MEDICINE

OUP accepted manuscript

(2018)   NUCLEIC ACIDS RESEARCH

Lung cancer: current therapies and new targeted treatments

(2017) Fred R Hirsch et al.   LANCET

The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer

(2017) Angela M. Krebs et al.   NATURE CELL BIOLOGY

Alternative polyadenylation of ZEB1 promotes its translation during genotoxic stress in pancreatic cancer cells

(2017) Ilaria Passacantilli et al.   Cell Death & Disease

A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies

(2016) Luisa de Latouliere et al.   ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER

Dissection of transcriptional andcis‐regulatory control of differentiation in human pancreatic cancer

(2016) Giuseppe R Diaferia et al.   EMBO JOURNAL

Genomic analyses identify molecular subtypes of pancreatic cancer

(2016) Peter Bailey et al.   NATURE

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

(2016) Elisa M Noll et al.   NATURE MEDICINE

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

(2015) Richard A Moffitt et al.   NATURE GENETICS

Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells

(2015) S Calabretta et al.   ONCOGENE

Splicing Regulation: A Molecular Device to Enhance Cancer Cell Adaptation

(2015) Vittoria Pagliarini et al.   Biomed Research International

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

(2014) L. Rahib et al.   CANCER RESEARCH

CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness

(2013) Bruno Pereira et al.   NUCLEIC ACIDS RESEARCH

Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia

(2012) Mitsuro Kanda et al.   GASTROENTEROLOGY

Molecular imaging of nuclear factor-Y transcriptional activity maps proliferation sites in live animals

(2012) Frauke Goeman et al.   MOLECULAR BIOLOGY OF THE CELL

Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cells

(2012) HONG JIANG et al.   Molecular Medicine Reports

Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway

(2012) L Adesso et al.   ONCOGENE